At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 32 enrolled
Drug / intervention
Glyoxalase 1 (Glo1) inducer +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dietary Inducers of Glyoxalase-1 for Prevention and Early-stage Alleviation of Age Related Health Disorders Through Functional Foods.
In Brief
A Phase 2 clinical trial evaluating Glyoxalase 1 (Glo1) inducer and Placebo for Glucose Intolerance and 2 related conditions. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether dietary inducers of glyoxalase 1 are effective in improving metabolic and vascular health.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlucose Intolerance, Aortic Stiffness, Vasodilation
CountriesUnited Kingdom
CollaboratorsTechnology Strategy Board, United Kingdom, Unilever R&D
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartMay 2014
Primary CompletionFeb 2015
Study CompletionMay 2015
TodayJul 2026
First PostedMar 26, 2014
Enrollment StartMay 1, 2014
Primary CompletionFeb 1, 2015
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 12.3 years ago
Interventions
Glyoxalase 1 (Glo1) inducerdietary
Dietary bioactive
Placebodietary
Mannitol, 108 mg